Sublocade is a long-acting, extended-release injectable form of buprenorphine used to treat opioid use disorder. At Advene Health, we offer Sublocade as part of our comprehensive Medication-Assisted Treatment program for individuals seeking a structured, consistent treatment option.
Sublocade provides steady medication levels for a full month, helping reduce cravings and withdrawal symptoms without the need for daily dosing.
Understanding Your Treatment
Provides consistent medication levels
Eliminates daily dosing requirements
Reduces risk of missed doses
Lowers misuse potential
Supports improved treatment adherence
Treatment includes
Sublocade may be beneficial for individuals who:
Prefer not to take daily medication
Struggle with adherence to oral dosing
Want a structured, long-acting option
Seek additional accountability
Are stable on buprenorphine and ready to transition
Advene Health accepts Medicaid, Medicare, Blue Cross Blue Shield, Cigna, Aetna, United Healthcare, and Tricare. For eligible patients, Sublocade may be covered under Medicaid and other insurance plans.
Our admissions team verifies benefits and explains coverage clearly before treatment begins.